Switch From Ozempic to Wegovy vs Mounjaro UK - From £69.00

Clinically Proven UK Registered Pharmacy

Cheapest Switch Ozempic to Wegovy UK - Compare Prices

Compare the cheapest UK prices when switching from Ozempic to Wegovy or Mounjaro, with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £89.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

How to Switch From Ozempic to Wegovy or Mounjaro: UK Clinical Guidance

Many patients looking to switch from Ozempic to Wegovy or Mounjaro do so to access higher licensed doses for weight management or due to supply considerations. Both Wegovy (semaglutide) and Mounjaro (tirzepatide) are MHRA-licensed specifically for weight loss, whereas Ozempic is licensed for type 2 diabetes, making the transition a clinically appropriate step for those prioritising weight reduction outcomes. Understanding the dose conversion, expected timelines, and comparative efficacy helps ensure a safe and effective switch under UK prescriber supervision.

Why Patients Switch From Ozempic to Wegovy or Mounjaro

Patients commonly switch from Ozempic to Wegovy because both contain the same active ingredient—semaglutide—but Wegovy is licensed at higher maintenance doses (up to 2.4 mg weekly) specifically for chronic weight management [1]. Ozempic's maximum licensed dose is 1 mg weekly for diabetes, which may not deliver the same weight loss outcomes observed in the STEP clinical trial programme [1]. Switching to Wegovy allows continuation of semaglutide therapy at the evidence-based dose proven to achieve average weight reductions of 15-17% in clinical trials [1].

Alternatively, switching from Ozempic to Mounjaro introduces a dual-action GLP-1/GIP receptor agonist, tirzepatide, which demonstrated superior weight loss compared to semaglutide in head-to-head SURPASS-2 trial data [2]. Patients achieving suboptimal results on Ozempic may benefit from Mounjaro's dual incretin pathway, which produced average weight reductions exceeding 20% at the 15 mg maintenance dose [2]. Both switches require clinical assessment by a UK-registered prescriber to ensure suitability and appropriate dose titration.

Dose Conversion When You Switch From Ozempic to Wegovy

Because Wegovy and Ozempic share the same active ingredient, the dose conversion when switching from Ozempic to Wegovy is straightforward. If you are currently stable on Ozempic 1 mg weekly, UK clinical guidance typically recommends transitioning directly to Wegovy 1.7 mg weekly, then escalating to the target dose of 2.4 mg after four weeks [3]. This graduated approach minimises gastrointestinal side effects commonly associated with GLP-1 receptor agonists.

For patients on lower Ozempic doses (0.25 mg or 0.5 mg weekly), the switch from Ozempic to Wegovy should follow the standard Wegovy titration schedule, starting at 0.25 mg weekly and increasing every four weeks until reaching the 2.4 mg maintenance dose [3]. Your prescriber will tailor the schedule based on tolerance and treatment response. All dose adjustments must be supervised by a UK-registered healthcare professional to ensure safety and efficacy.

Timing Your Switch From Ozempic to Wegovy

Most UK prescribers advise administering your first Wegovy dose one week after your final Ozempic injection, maintaining the once-weekly rhythm without overlap [3]. Because semaglutide has a half-life of approximately one week, this interval prevents excessive drug accumulation while ensuring continuous GLP-1 receptor activity. Patients should not double-dose or shorten the interval without prescriber approval.

How to Switch From Ozempic to Mounjaro Safely

Switching from Ozempic to Mounjaro involves changing to a different active ingredient—tirzepatide—which acts on both GLP-1 and GIP receptors. UK clinical protocols recommend stopping Ozempic and initiating Mounjaro at the starting dose of 2.5 mg weekly, regardless of your previous Ozempic dose [4]. This conservative approach accounts for tirzepatide's distinct pharmacology and side effect profile, allowing your body to adjust to the dual incretin mechanism.

After four weeks on Mounjaro 2.5 mg, the dose is typically increased to 5 mg weekly, with further escalations every four weeks up to a maximum of 15 mg weekly, depending on treatment response and tolerability [4]. Clinical trial data from SURPASS-2 showed that tirzepatide 15 mg produced significantly greater weight loss than semaglutide 1 mg, with average reductions of 11.2 kg versus 5.7 kg over 40 weeks [2]. All patients switching from Ozempic to Mounjaro must complete an online clinical assessment with a UK-registered prescriber to confirm suitability and receive personalised dosing guidance.

Managing Side Effects When Switching From Ozempic to Mounjaro

Even though you have tolerated Ozempic, switching from Ozempic to Mounjaro may still cause transient gastrointestinal symptoms—nausea, diarrhoea, or constipation—as your body adapts to the GIP receptor activity [4]. These effects are typically mild to moderate and diminish within the first few weeks. Eating smaller, more frequent meals and avoiding high-fat foods can help manage symptoms during the transition period.

Treatment Active Ingredient Maximum Dose Starting Price (UK)
Ozempic Semaglutide 1 mg weekly Not sold at Cured Pharmacy
Wegovy Semaglutide 2.4 mg weekly From £89.00
Mounjaro Tirzepatide 15 mg weekly From £145.00

Comparing Efficacy: Switch From Ozempic to Wegovy vs Mounjaro

When deciding whether to switch from Ozempic to Wegovy or Mounjaro, comparative efficacy data provides valuable insight. The STEP 1 trial demonstrated that semaglutide 2.4 mg (Wegovy) achieved average weight loss of 14.9% versus 2.4% with placebo over 68 weeks [1]. In contrast, the SURMOUNT-1 trial showed tirzepatide 15 mg (Mounjaro) delivered average weight reductions of 20.9% versus 3.1% with placebo over 72 weeks [5]. While head-to-head trials directly comparing Wegovy 2.4 mg to Mounjaro 15 mg remain limited, available evidence suggests tirzepatide may offer incremental weight loss benefits for some patients.

However, individual response varies significantly, and switching from Ozempic to Wegovy may be preferable for patients who respond well to semaglutide and wish to continue the same active ingredient at a higher licensed dose. Conversely, those experiencing plateaued weight loss on Ozempic may benefit from switching from Ozempic to Mounjaro to access the dual incretin pathway. Your UK prescriber will assess your treatment history, comorbidities, and weight loss goals to recommend the most appropriate option.

UK Pricing and Availability When You Switch From Ozempic to Wegovy or Mounjaro

At Cured Pharmacy, patients switching from Ozempic to Wegovy benefit from transparent upfront pricing, with Wegovy available from £69.00 per month, subject to prescriber approval. New patients can Save £20 on their first order using code Weightlossnew, making the transition both clinically sound and cost-effective. All Wegovy prescriptions include a free online consultation with a UK-registered prescriber, completed in under three minutes, ensuring continuity of care during your switch.

For those switching from Ozempic to Mounjaro, Cured Pharmacy offers Mounjaro from £69.00 per month, again with the £69.00 first-order discount available. Both treatments are dispensed as genuine UK-licensed medicines, delivered in discreet packaging with next-day delivery options across the UK. Transparent pricing before consultation allows patients to make informed decisions without hidden costs, and our GPhC-registered pharmacy (9012511) under superintendent pharmacist Tarun Kumar ensures every prescription meets UK regulatory standards.

Prescription Requirements for Switching From Ozempic to Wegovy or Mounjaro

Both Wegovy and Mounjaro are prescription-only medicines in the UK, requiring clinical assessment by a UK-registered prescriber even if you are currently taking Ozempic. The online consultation reviews your medical history, current medications, weight loss progress, and any contraindications to ensure safe prescribing. Approval is not guaranteed and depends on clinical suitability, but most patients switching from Ozempic meet eligibility criteria for either Wegovy or Mounjaro.

Step-by-Step Guide to Switch From Ozempic to Wegovy or Mounjaro at Cured Pharmacy

Switching from Ozempic to Wegovy or Mounjaro through Cured Pharmacy follows a simple, clinically governed process. First, complete the free online consultation, providing details of your current Ozempic dose, treatment duration, weight loss achieved, and any side effects experienced. A UK-registered prescriber reviews your assessment, typically within hours, and determines whether Wegovy or Mounjaro is the most appropriate next step based on your individual circumstances.

Once approved, your prescription is dispensed by our GPhC-registered pharmacy and dispatched via next-day delivery in 100% discreet packaging. Your first Wegovy or Mounjaro injection should be administered one week after your final Ozempic dose, following the titration schedule provided by your prescriber. Ongoing clinical support is available via phone (+44 116 4646009) or email, ensuring you have expert guidance throughout your switch from Ozempic to Wegovy or Mounjaro. All follow-up prescriptions require repeat consultation to monitor progress and adjust dosing as needed.

Monitoring and Follow-Up After Switching From Ozempic to Wegovy or Mounjaro

Regular monitoring is essential after switching from Ozempic to Wegovy or Mounjaro to assess treatment response, manage side effects, and optimise dosing. UK clinical guidelines recommend reviewing weight loss progress every 4-12 weeks, with dose escalation contingent on tolerability and efficacy [3]. Patients should report any persistent nausea, vomiting, or abdominal pain to their prescriber, as these may indicate the need for dose adjustment or additional supportive measures.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from eMC. [accessed 15 August 2026]
  4. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from eMC. [accessed 15 August 2026]
  5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & SURMOUNT-1 Investigators. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I switch from Ozempic to Wegovy immediately?
Yes, you can switch from Ozempic to Wegovy after completing a clinical assessment with a UK prescriber. Administer your first Wegovy dose one week after your final Ozempic injection to maintain once-weekly continuity.
Is Mounjaro better than Wegovy if I switch from Ozempic?
Clinical trials suggest Mounjaro (tirzepatide) may deliver greater average weight loss than Wegovy (semaglutide), but individual response varies. Your UK prescriber will recommend the most suitable option based on your treatment history and goals.
What dose of Wegovy should I start on when switching from Ozempic 1 mg?
Most UK prescribers recommend transitioning from Ozempic 1 mg to Wegovy 1.7 mg weekly, then escalating to 2.4 mg after four weeks, subject to tolerability and prescriber guidance.
Will I experience side effects when I switch from Ozempic to Mounjaro?
Some patients experience mild gastrointestinal symptoms when switching from Ozempic to Mounjaro as the body adapts to tirzepatide's dual incretin action. These effects typically resolve within a few weeks and can be managed with dietary adjustments.
How much does it cost to switch from Ozempic to Wegovy at Cured Pharmacy?
Wegovy is available from £69.00 per month at Cured Pharmacy, with £20 off your first order using code Weightlossnew. All prescriptions include a free UK prescriber consultation.
Do I need a new prescription to switch from Ozempic to Wegovy?
Yes, switching from Ozempic to Wegovy requires a new prescription issued by a UK-registered prescriber, even though both contain semaglutide, because they are licensed for different indications and doses.
Can I switch from Ozempic to Mounjaro if I have type 2 diabetes?
Yes, Mounjaro is licensed for type 2 diabetes management in the UK and may be suitable when switching from Ozempic, subject to clinical assessment and prescriber approval based on your glycaemic control and weight loss goals.
How long does it take to see results after switching from Ozempic to Wegovy or Mounjaro?
Most patients notice continued or enhanced weight loss within 4-8 weeks of switching from Ozempic to Wegovy or Mounjaro, with optimal results typically achieved after reaching the maintenance dose and maintaining it for several months.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.